Compliance of extended infusion of piperacillin/tazobactam with the desired pharmacokinetic/pharmacodynamic index in septic patients
Background/Aim. Piperacillin (PIP)/tazobactam (TAZ) –PIP/TAZ is a beta-lactam antibiotic used to treat Gram-negative sepsis. The portion of the dosing interval during which antibiotic concentrations are above the minimal inhibitory concentration – MIC (fT>MIC) or, even more, four times higher tha...
Saved in:
| Main Authors: | Tomić Nataša, Vukmirović Saša, Sabo Stanislav, Uvelin Arsen, Popović Radmila, Vicković Sanja, Tomić Ljiljana, Tomić Zdenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2025-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | https://doiserbia.nb.rs/img/doi/0042-8450/2025/0042-84502500029T.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Piperacillin-tazobactam: prospects for use in real-world practice
by: Yu. M. Gomon
Published: (2023-10-01) -
The role of piperacillin/tazobactam in the treatment of Hidradenitis suppurativa
by: Aviv Barzilai, et al.
Published: (2024-12-01) -
Suitability of Piperacillin–Tazobactam for Treating Dogs Infected with Extended-Spectrum β-Lactamase-Producing Enterobacterales: Pharmacokinetic and Pharmacodynamic Analysis
by: Kazuki Harada, et al.
Published: (2025-04-01) -
Piperacillin/Tazobactam as Cause of Acute Generalized Exanthematous Pustulosis
by: Aikaterini Kyriakou, et al.
Published: (2019-01-01) -
Prolonged infusion of β-lactam antibiotics decreases short-term mortality in critically ill patients: A meta-analysis and trial sequential analysis from randomized control trials
by: Baofang Liang, et al.
Published: (2025-09-01)